L
Lore Marretta
Publications - 1
Citations - 216
Lore Marretta is an academic researcher. The author has contributed to research in topics: Survival rate & Midostaurin. The author has an hindex of 1, co-authored 1 publications receiving 132 citations.
Papers
More filters
Journal ArticleDOI
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Richard F. Schlenk,Richard F. Schlenk,Daniela Weber,Walter Fiedler,Helmut R. Salih,Gerald Wulf,Hans Salwender,Thomas Schroeder,Thomas Kindler,Michael Lübbert,Dominik Wolf,Jörg Westermann,Doris Kraemer,Katharina Götze,Heinz-August Horst,Jürgen Krauter,Michael Girschikofsky,Mark Ringhoffer,Thomas Südhoff,Gerhard Held,Hans-Günter Derigs,Roland Schroers,Richard Greil,Martin Grießhammer,Elisabeth Lange,Alexander Burchardt,Uwe M. Martens,Bernd Hertenstein,Lore Marretta,Michael Heuser,Felicitas Thol,Verena I. Gaidzik,Wolfgang Herr,Julia Krzykalla,Axel Benner,Konstanze Döhner,Arnold Ganser,Peter Paschka,Hartmut Döhner +38 more
TL;DR: A phase 2 hypothesis-generating trial to determine whether the addition of the multitargeted kinase inhibitor midostaurin to intensive chemotherapy followed by allogeneic hematopoietic cell transplantation and single-agent maintenance therapy of 12 months is feasible and favorably influences event-free survival (EFS) compared with historical controls.